RayOne EMV Toric receives Health Canada approval
Posted on 23/01/2025
Mississauga, ON | 21 January 2025
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, is pleased to announce the approval of RayOne EMV Toric (RAO210T) by Health Canada.
Developed in collaboration with Professor Graham Barrett, RayOne EMV and RayOne EMV Toric are the only patented aspheric IOLs that induce controlled positive spherical aberration to extend depth of focus, with RayOne EMV Toric providing astigmatism correction and offering Canadian surgeons a new option for achieving high-quality visual outcomes.
Devinder Cheema MD CM FRCS ABO, Department of Ophthalmology and Visual Sciences at McGill University, said “The approval of RayOne EMV Toric is exciting, as it allows me to extend the benefits of the RayOne EMV platform to patients with astigmatism. It’s a great opportunity to provide the same high-quality vision to an even broader group of patients,”
Dr Paul Sanghera, Co-Found of Lumea and Clarity Eye Institute, echoed “I’ve seen great results with RayOne EMV and am thrilled that the toric version is now available in Canada. This will be a valuable option for patients with astigmatism who want the same excellent outcomes we’ve come to expect from EMV.”
Rayner has a rich history of innovation and a commitment to improving the lives of cataract patients since manufacturing the world’s first intraocular lens (IOL) in 1949. The approval of RayOne EMV Toric marks an important milestone for Rayner in delivering advanced solutions to Canadian surgeons and patients.
About Rayner:
Since the implantation of the first Rayner intraocular lens by Sir Harold Ridley 1949, Rayner has had the goal to improve vision and restore sight worldwide. Today, Rayner’s mission remains to deliver innovative and clinically superior ophthalmic products that respond to the expectations of our global customers to improve the sight and quality of life of their patients.
Headquartered in Worthing, United Kingdom, Rayner markets its medical devices, pharmaceuticals, and digital solutions worldwide in over 80 countries through a network of distributors and includes direct sales teams in the United Kingdom, Eire, USA, Canada, Brazil, India, Poland, Australia, Germany, Austria, Switzerland, France, Italy, Spain, and Portugal.
Not all Rayner products are approved for sale in every country. Please contact your local Rayner distributor for details of which products are available in your area.
©2025 Rayner Group, all rights reserved. ‘Rayner’, ‘RayOne’ and ‘EMV’ are proprietary marks of the Rayner Group. All other trademarks are property of their respective owners.
Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ | EC-2025-04 EN